Clinical Trials Verified stories whose regulatory record supports clinical-trial access. Eligibility and enrollment are never guaranteed.
Filter clinical trials Filters Results 97 verified trial-access stories match your filters.
Important: Eligibility and enrollment are not guaranteed, and listing here is not a treatment recommendation. Talk to your care team.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT05827081
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants ages 18 Years to 100 Years with Early Breast Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-18 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-18 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT07544056
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants ages 18 Years to 75 Years with Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-08-18 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-18 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT07431827
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Non-small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-17 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-17 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Leukemia
Trial identifier NCT07223021
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 1 Year and older with B-cell Acute Lymphoblastic Leukemia who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-17 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-17 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Stomach (Gastric) Cancer
Trial identifier NCT07392892
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-17 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-17 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT07365241
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-14 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-14 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lymphoma
Trial identifier NCT07634471
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Follicular Lymphoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-14 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-14 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Kidney (Renal) Cancer
Trial identifier NCT04736706
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Carcinoma, Renal Cell who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-14 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-14 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT06875310
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Carcinoma, Non-Small-Cell Lung who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-14 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-14 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT07391774
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-14 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-14 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
CancerDiscoveries summarizes verified records in its database. Absence of a listing here does not establish that a treatment lacks regulatory authorization or access.